J

Jinyu Bio-Technology Co Ltd
SSE:600201

Watchlist Manager
Jinyu Bio-Technology Co Ltd
SSE:600201
Watchlist
Price: 7.13 CNY -0.14% Market Closed
Market Cap: 8B CNY
Have any thoughts about
Jinyu Bio-Technology Co Ltd?
Write Note

Jinyu Bio-Technology Co Ltd
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Jinyu Bio-Technology Co Ltd
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
J
Jinyu Bio-Technology Co Ltd
SSE:600201
Other Liabilities
ÂĄ637.8m
CAGR 3-Years
26%
CAGR 5-Years
35%
CAGR 10-Years
35%
Beigene Ltd
HKEX:6160
Other Liabilities
ÂĄ1.6B
CAGR 3-Years
-18%
CAGR 5-Years
3%
CAGR 10-Years
N/A
Innovent Biologics Inc
HKEX:1801
Other Liabilities
ÂĄ1.4B
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Other Liabilities
ÂĄ33.6m
CAGR 3-Years
-29%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Other Liabilities
ÂĄ215.4m
CAGR 3-Years
-4%
CAGR 5-Years
19%
CAGR 10-Years
13%
Imeik Technology Development Co Ltd
SZSE:300896
Other Liabilities
ÂĄ3.4m
CAGR 3-Years
-30%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
No Stocks Found

Jinyu Bio-Technology Co Ltd
Glance View

Market Cap
8B CNY
Industry
Biotechnology

Jinyu Bio-Technology Co Ltd., a hallmark of scientific innovation and agricultural care, operates at the intersection of biotech and animal health services, focusing primarily on the production of vaccines for livestock. Founded with the vision to enhance animal well-being and agricultural productivity, the company's trajectory has been marked by a commitment to research and development. This dedication is evidenced by its expansive portfolio, which features an array of vaccines aimed at safeguarding livestock against prevalent and virulent diseases. By investing heavily in R&D, Jinyu ensures that its product offerings remain at the frontier of technological advancement and efficacy. The company's modern facilities, equipped with state-of-the-art technology, facilitate the production of high-quality vaccines that adhere to international standards. The company's business model is intricately tied to its strategic positioning within the agricultural ecosystem. By catering to a critical segment—livestock and poultry farmers—Jinyu not only supplies essential vaccines but also provides veterinary services and support, ensuring a holistic approach to animal health. This dual role as a product supplier and service provider enables Jinyu Bio-Technology Co Ltd. to forge long-lasting relationships with its clientele, enhancing customer loyalty and creating a stable revenue stream. Moreover, its efforts in capturing emerging markets, particularly in regions where agricultural development is accelerating, signal a forward-thinking approach that seeks to tap into new growth avenues. Through these strategies, Jinyu continues to reinforce its stature as a pivotal player in the animal health domain, working diligently to marry profitability with sustainable agricultural development.

Intrinsic Value
10.74 CNY
Undervaluation 34%
Intrinsic Value
Price
J

See Also

What is Jinyu Bio-Technology Co Ltd's Other Liabilities?
Other Liabilities
637.8m CNY

Based on the financial report for Sep 30, 2024, Jinyu Bio-Technology Co Ltd's Other Liabilities amounts to 637.8m CNY.

What is Jinyu Bio-Technology Co Ltd's Other Liabilities growth rate?
Other Liabilities CAGR 10Y
35%

Over the last year, the Other Liabilities growth was 76%. The average annual Other Liabilities growth rates for Jinyu Bio-Technology Co Ltd have been 26% over the past three years , 35% over the past five years , and 35% over the past ten years .

Back to Top